Ageotypes and Modern Longevity Biomarkers: What Physicians Should Monitor Beyond Telomeres Key Takeaways Stanford's ageotypes framework revolutionizes aging assessment by identifying four distinct aging patterns—metabolic, immune, hepatic, and nephrotic—enabling personalized longevity interventions beyond traditional approaches. • Telomeres alone are insufficient: Individual variation and tissue-specific differences
Tag: inflammaging
The Cancer Risk Paradox of Anti-Aging Therapies
The Cancer Risk Paradox of Anti-Aging Therapies Abstract The relationship between anti-aging interventions and cancer risk presents a complex biological paradox that demands careful examination by healthcare practitioners. While many anti-aging therapies aim to promote cellular health and longevity, they may inadvertently create conditions that
The New Frontier in Longevity Science: Senolytics and Age-Reversal Therapies
The New Frontier in Longevity Science: Senolytics and Age-Reversal Therapies Introduction Approximately 80% of adults over age 65 worldwide develop at least one chronic condition, from arthritis to dementia. Recent longevity research has identified cellular senescence as a fundamental driver of age-related decline. These
